sales $34.461 million, eps 8.57c, div 2c, page-12

Reading the posts, day after day, there was a natural inclination to have too high an expectation.
now that the result is out it is time for reflection on the facts so far and the expected future performance.

facts
(1) QFT is gaining market share from TST GLOBALLY
(2) Conference after conference and study after study confirms QFT's growing prominence
(3) TB has infected 2Billion people and the West through immigration is experiencing renewed infection rates
(4)in the IGRA sphere QFT has no competitor to fear
(5) The area of medical diagnostics is an extremely conservative area. Change is very slow for a variety of reasons. It is very bureacratic. Everybody is checked to see if they follow due process. And at the moment the process includes TST and it has been around for over 100 yrs. Systems are used to TST
(6) The profit figures are very good . We have 2C FF and good prospects for more.
(7) CST is not mentioned in today's AFR. Just shows you how much of a journey we have to travel